NO20022828L - Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse - Google Patents

Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse

Info

Publication number
NO20022828L
NO20022828L NO20022828A NO20022828A NO20022828L NO 20022828 L NO20022828 L NO 20022828L NO 20022828 A NO20022828 A NO 20022828A NO 20022828 A NO20022828 A NO 20022828A NO 20022828 L NO20022828 L NO 20022828L
Authority
NO
Norway
Prior art keywords
amino
triazole
phenyl
processes
preparation
Prior art date
Application number
NO20022828A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022828D0 (no
Inventor
Michel Geslin
Danielle Gully
Jean-Pierre Maffrand
Pierre Roger
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Publication of NO20022828D0 publication Critical patent/NO20022828D0/no
Publication of NO20022828L publication Critical patent/NO20022828L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Gynecology & Obstetrics (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20022828A 1999-12-17 2002-06-13 Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse NO20022828L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9915935A FR2802530B1 (fr) 1999-12-17 1999-12-17 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
PCT/FR2000/003536 WO2001044207A2 (fr) 1999-12-17 2000-12-14 Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2 4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant

Publications (2)

Publication Number Publication Date
NO20022828D0 NO20022828D0 (no) 2002-06-13
NO20022828L true NO20022828L (no) 2002-08-19

Family

ID=9553380

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022828A NO20022828L (no) 1999-12-17 2002-06-13 Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for deres fremstilling, ogfarmasöytiske preparater inneholdende disse

Country Status (33)

Country Link
US (1) US6806282B2 (cs)
EP (1) EP1242389B1 (cs)
JP (1) JP4146641B2 (cs)
KR (1) KR100705525B1 (cs)
CN (1) CN1293061C (cs)
AR (1) AR031837A1 (cs)
AT (1) ATE264847T1 (cs)
AU (1) AU780711B2 (cs)
BR (1) BR0017023A (cs)
CA (1) CA2398772C (cs)
CO (1) CO5251379A1 (cs)
CZ (1) CZ302460B6 (cs)
DE (1) DE60010126T2 (cs)
DK (1) DK1242389T3 (cs)
EA (1) EA004957B1 (cs)
EE (1) EE04778B1 (cs)
ES (1) ES2219436T3 (cs)
FR (1) FR2802530B1 (cs)
HU (1) HUP0204080A3 (cs)
IL (2) IL150037A0 (cs)
IS (1) IS2315B (cs)
ME (1) MEP12108A (cs)
MX (1) MXPA02006033A (cs)
NO (1) NO20022828L (cs)
PL (1) PL203819B1 (cs)
PT (1) PT1242389E (cs)
RS (1) RS50289B (cs)
SK (1) SK285994B6 (cs)
TR (2) TR200201600T2 (cs)
TW (1) TWI289554B (cs)
UA (1) UA73333C2 (cs)
WO (1) WO2001044207A2 (cs)
ZA (1) ZA200204422B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2004263148B2 (en) * 2003-08-06 2008-08-21 Vertex Pharmaceuticals, Incorporated Aminotriazole compounds useful as inhibitors of protein kinases
JO3019B1 (ar) 2006-04-19 2016-09-05 Janssen Pharmaceutica Nv ثلاثي مستبدل 4،2،1-ثلاثي زولات
JO2784B1 (en) 2007-10-18 2014-03-15 شركة جانسين فارماسوتيكا ان. في 5,3,1 - Triazole substitute derivative
JP2011500625A (ja) 2007-10-18 2011-01-06 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ トリ置換された１，２，４−トリアゾール
MY152486A (en) 2008-03-19 2014-10-15 Janssen Pharmaceutica Nv Trisubstituted 1,2,4 - triazoles as nicotinic acetylcholine receptor modulators
WO2009135944A1 (en) 2008-05-09 2009-11-12 Janssen Pharmaceutica Nv Trisubstituted pyrazoles as acetylcholine receptor modulators
WO2012054366A2 (en) * 2010-10-21 2012-04-26 Merck Sharp & Dohme Corp. Substituted amino-triazolyl pde10 inhibitors
JP6585625B2 (ja) 2014-01-21 2019-10-02 ニューロクライン バイオサイエンシーズ，インコーポレイテッド 先天性副腎皮質過形成の処置のためのｃｒｆ１レセプターアンタゴニスト
CN104059027B (zh) * 2014-07-01 2015-10-28 河北大学 一类含1,2,4-三唑的(e)-甲氧基亚氨基苯乙酸甲酯类化合物及其制备方法和用途
MA54395A (fr) 2018-12-07 2022-03-16 Neurocrine Biosciences Inc Antagoniste du récepteur crf1, formulations pharmaceutiques et formes solides correspondantes pour le traitement de l'hyperplasie surrénalienne congénitale
CA3155177A1 (en) * 2019-09-25 2021-04-01 Oncoarendi Therapeutics S.A. Process for the production of 5-(4-((2s,5s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1h-1,2,4-triazol-3-amine
CN114502162B (zh) 2019-09-27 2025-03-28 纽罗克里生物科学有限公司 Crf受体拮抗剂及使用方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0285893B1 (en) * 1987-03-27 1992-03-18 Kumiai Chemical Industry Co., Ltd. Phenyltriazole derivative and insecticide
US5795905A (en) * 1995-06-06 1998-08-18 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
FR2763337B1 (fr) * 1997-05-13 1999-08-20 Sanofi Sa Nouveaux derives du triazole, un procede pour leur preparation et compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
IL150037A (en) 2007-02-11
JP2003516975A (ja) 2003-05-20
WO2001044207A3 (fr) 2001-12-20
IS6402A (is) 2002-05-28
SK8502002A3 (en) 2003-02-04
IL150037A0 (en) 2002-12-01
PT1242389E (pt) 2004-08-31
PL355811A1 (en) 2004-05-17
ATE264847T1 (de) 2004-05-15
IS2315B (is) 2007-11-15
CZ20022099A3 (cs) 2002-09-11
ES2219436T3 (es) 2004-12-01
TR200201600T2 (tr) 2002-10-21
KR20020061002A (ko) 2002-07-19
WO2001044207A8 (fr) 2001-07-12
HK1055947A1 (en) 2004-01-30
DK1242389T3 (da) 2004-08-09
AU2525901A (en) 2001-06-25
DE60010126T2 (de) 2005-04-28
UA73333C2 (en) 2005-07-15
EE200200331A (et) 2003-06-16
AU780711B2 (en) 2005-04-14
RS50289B (sr) 2009-09-08
CN1293061C (zh) 2007-01-03
KR100705525B1 (ko) 2007-04-10
MXPA02006033A (es) 2003-01-28
US6806282B2 (en) 2004-10-19
FR2802530A1 (fr) 2001-06-22
CA2398772C (fr) 2011-07-05
HUP0204080A2 (hu) 2003-04-28
ZA200204422B (en) 2003-11-26
PL203819B1 (pl) 2009-11-30
CZ302460B6 (cs) 2011-06-01
FR2802530B1 (fr) 2002-02-22
DE60010126D1 (de) 2004-05-27
US20030162771A1 (en) 2003-08-28
WO2001044207B1 (fr) 2002-06-06
CA2398772A1 (fr) 2001-06-21
HUP0204080A3 (en) 2005-01-28
BR0017023A (pt) 2002-12-03
EP1242389B1 (fr) 2004-04-21
SK285994B6 (sk) 2008-01-07
EE04778B1 (et) 2007-02-15
MEP12108A (en) 2010-06-10
TWI289554B (en) 2007-11-11
EA200200523A1 (ru) 2002-12-26
YU43902A (sh) 2005-03-15
TR200401775T4 (tr) 2004-09-21
JP4146641B2 (ja) 2008-09-10
EP1242389A2 (fr) 2002-09-25
WO2001044207A2 (fr) 2001-06-21
CO5251379A1 (es) 2003-02-28
EA004957B1 (ru) 2004-10-28
NO20022828D0 (no) 2002-06-13
CN1434808A (zh) 2003-08-06
AR031837A1 (es) 2003-10-08

Similar Documents

Publication Publication Date Title
NO20002721D0 (no) Heterocykliske forbindelser for inhibitering av gastrisk syresekresjon, fremgangsmÕter for deres fremstilling og farmasøytiske preparater derav
NO995006L (no) Nye forbindelser
NO20013736D0 (no) Pyrazolkarboksylsyrederivater, deres fremstilling og farmasöytiske preparater inneholdende de samme
EP1037639A4 (en) HETEROARYL-SUBSTITUTED IMIDAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES
HUP0102022A3 (en) Stabilized pharmaceutical preparations of gamma-aminobutyric acid derivatives and process for preparing the same
SI1156049T1 (en) Substituted heterocyclic compounds, their process of preparation and pharmaceutical compositions containing them
NO20012983D0 (no) Nye malonsyrederivater, fremgangsmåter for fremstilling derav, og farmasöytiske preparater inneholdende disse (inhiberingav faktor Xa-aktivitet)
FR13C0010I2 (fr) Composes d'indazole et compositions pharmaceutiques inhibant les proteines kinases, et procedes d'utilisation de ceux-ci
EP1006110B8 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments
NO985368L (no) Substituerte imidazolidinderivater, deres fremstilling, deres anvendelse og farmas°ytiske preparater inneholdende forbindelsene
NO985262L (no) Nye fosfonsyresubstituerte benzazepinon-N-edikksyrederivater, fremgangsmÕte for deres fremstilling, og legemidler inneholdende slike
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
AU1307399A (en) Stabilized, dry pharmaceutical compositions for drug delivery and methods of preparing same
NO20022828D0 (no) Nye forgrenede substituerte aminoderivater av 3-amino-1-fenyl- 1H[1,2,4]triazol, fremgangsmåter for fremstilling av disse, ogfarmasöytiske preparater inneholdende disse
HRP980258B1 (en) New triazole derivatives, process for the preparation thereof and pharmaceutical preparations containing them
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
AU2428799A (en) Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
AU2001252711A1 (en) Aqueous-prodrug compound comprising moiety of paclitxel or derivatives thereof, method of preparing same and pharmaceutical composition comprising same
AU1700801A (en) Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
NO20005391D0 (no) Nye oktahydro-6,10-diokso-6H-pyridazino[1,2-a][1,2]diazepin-1- karboksylsyrederivater, fremgangsmÕte for fremstilling av disse samt deres anvendelse for fremstilling av terapeutisk aktive preparater
AU7305496A (en) Novel acid pyrazole derivatives, preparation method therefor, use thereof as drugs, novel use therefor, and pharmaceutical compositions containing such derivatives
NO20020777D0 (no) Farmasöytiske preparater inneholdende derivater og fremgangsmåte for fremstilling derav
NO960664D0 (no) Substituerte benzensulfonylureaer og -tioureaer, fremgangsmåter for deres fremstilling, deres anvendelse for fremstilling av farmasöytiske preparater og medikamenter inneholdende disse
NO20014383L (no) Fremgangsmåte for fremstilling av syklo-(Asp-DPhe-NMeVal-Arg- Gly)
AU6308900A (en) Isoquinoline derivatives, pharmaceutical compositions containing the same, and a process for the preparation of the active substance

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application